Your browser doesn't support javascript.
loading
Defining aggressive prostate cancer: a geospatial perspective.
Wiese, Daniel; DuBois, Tesla D; Sorice, Kristen A; Fang, Carolyn Y; Ragin, Camille; Daly, Mary B; Reese, Adam C; Henry, Kevin A; Lynch, Shannon M.
Afiliação
  • Wiese D; Department of Surveillance and Health Equity Science, American Cancer Society, 3380 Chastain Meadows Pkwy NW Suite 200, Kennesaw, GA, 30144, USA. daniel.wiese@cancer.org.
  • DuBois TD; Department of Geography, Temple University, Philadelphia, PA, USA. daniel.wiese@cancer.org.
  • Sorice KA; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Fang CY; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ragin C; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Daly MB; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Reese AC; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Henry KA; Temple Health Urology, Philadelphia, PA, USA.
  • Lynch SM; Department of Geography, Temple University, Philadelphia, PA, USA.
BMC Cancer ; 23(1): 754, 2023 Aug 14.
Article em En | MEDLINE | ID: mdl-37580675
ABSTRACT

BACKGROUND:

Spatial analysis can identify communities where men are at risk for aggressive prostate cancer (PCan) and need intervention. However, there are several definitions for aggressive PCan. In this study, we evaluate geospatial patterns of 3 different aggressive PCan definitions in relation to PCan-specific mortality and provide methodologic and practical insights into how each definition may affect intervention targets.

METHODS:

Using the Pennsylvania State Cancer Registry data (2005-2015), we used 3 definitions to assign "aggressive" status to patients diagnosed with PCan. Definition one (D1, recently recommended as the primary definition, given high correlation with PCan death) was based on staging criteria T4/N1/M1 or Gleason score ≥ 8. Definition two (D2, most frequently-used definition in geospatial studies) included distant SEER summary stage. Definition three (D3) included Gleason score ≥ 7 only. Using Bayesian spatial models, we identified geographic clusters of elevated odds ratios for aggressive PCan (binomial model) for each definition and compared overlap between those clusters to clusters of elevated hazard ratios for PCan-specific mortality (Cox regression).

RESULTS:

The number of "aggressive" PCan cases varied by definition, and influenced quantity, location, and extent/size of geographic clusters in binomial models. While spatial patterns overlapped across all three definitions, using D2 in binomial models provided results most akin to PCan-specific mortality clusters as identified through Cox regression. This approach resulted in fewer clusters for targeted intervention and less sensitive to missing data compared to definitions that rely on clinical TNM staging.

CONCLUSIONS:

Using D2, based on distant SEER summary stage, in future research may facilitate consistency and allow for standardized comparison across geospatial studies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos